RELT and breast cancer: Given the expression of endogenous RELT in 231 cells and the importance of chemotherapeutic agents to the treatment of BC, we sought to test whether the expression of RELT sensitizes 231 cells to two different chemotherapeutic agents commonly used in the treatment of BC, doxorubicin and paclitaxel (Taxol).